This study aims to understand the industry perspective on drivers and challenges for a successful la...
Read moreMedicine prices in Greece are set by the IRP. IRP is the process of using the prices in other countr...
Read moreIs the evidence base for high-cost CAR T-cell therapies Kymriah and Yescarta sufficient to be grante...
Read moreWe are delighted to say that we have received fabulous feedback, with responses from 15 industry exe...
Read moreZolgensma launched in May 2019 in the US for $2.1 million, whilst Zynteglo was launched in the EU in...
Read moreIn England, to gain a positive recommendation for use within the NHS from NICE, pharmaceutical produ...
Read moreA targeted drug has been accepted for routine use on the NHS in England for some adults with untreat...
Read moreBy joining together, countries can combine their resources to potentially increase the efficiency of...
Read morePharmaceutical pricing and market access is the crucial challenge for successful product launch toda...
Read moreWhat is the future of precision medicine in the EU? The field of precision medicine is a complex are...
Read more